Roger Devlin
Persimmon
William Drake
Owl Private Office

Simon Dingemans

Simon Dingemans

Biography

Simon Dingemans is currently Chair of the Financial Reporting Council and acts as an independent consultant and advisor.

Previously, Simon was Chief Financial Officer of GlaxoSmithKline for over eight years. At GSK he was a member of the Board and Corporate Executive Team (CET), and was directly involved in developing and delivering the strategy of the Company and driving its operational performance. As CFO he was responsible for leading Finance and a variety of other group functions, including Real Estate and Procurement, Technology and IT.

Before joining GSK, Mr. Dingemans was an investment banker for 25 years. He spent the first ten years of his career at S.G. Warburg, starting as a graduate trainee, before moving to Goldman Sachs in 1995. Over 15 years with Goldman Sachs, Including 10 years as a Partner of the Firm, he ran UK investment banking and was a leader of its European Mergers and Acquisitions business. During his time at Goldman Sachs, he came to be one of the most prolific and respected Mergers and Acquisitions bankers in Europe advising on some of the largest and most complex transactions valued at over $500 billion in aggregate.

Previously, Simon served as Chairman of the 100 Group which represents the views of the Finance Directors of FTSE 100 and a number of large UK private companies. He is currently a trustee of the Donmar Warehouse Theatre. He holds a Masters degree in Geography from Oxford University.

Simon Dingemans’ Newsfeed

New FRC chairman backs Big Four split

Simon Dingemans, the recently appointed chair of the Financial Reporting Council (FRC), has backed reforms to split the big six firms... They ranged from an operational split to a complete structural split. Dingemans started his role at the FRC last month in preparation for its transition to the Audit, Reporting and Governance Authority (ARGA)...

MPs call for audit watchdog to reform after endorsing new chair Simon Dingemans

An influential committee of MPs has called for radical reforms from Britain’s accountancy watchdog after endorsing the appointment of its proposed new chair.  Parliament’s Business, Energy and Industrial Strategy Committee (Beis) has given its approval for Simon Dingemans to take over as chair of the Financial Reporting Council (FRC)...

Simon Dingemans’ Background

Chair
Oct 2019 - Present
London, UK
The FRC set the UK’s Corporate Governance and Stewardship Codes and regulates accountants, auditors and actuaries. The FRC is due to be replaced by a new regulator – the Audit, Reporting and Governance Authority (ARGA)
Chief Financial Officer
Jan 2011 - May 2019
London, UK
GlaxoSmithKline is a pharmaceutical company which consists of three global businesses. It focuses on research, developing and manufacturing innovative pharmaceutical vaccines, medicines and consumer healthcare products.
View allHide

Previous Non-Executive Positions

Chairman
2014 - 2016
London, UK
The 100 Group represents the views of the Finance Directors of FTSE 100 and a number of large UK private companies. It is organised through a structure of committees, who meet regularly to debate emerging topics on the agenda of Finance Directors.

Philanthropy

Trustee
2018 - Present
London, UK
A not-for-profit theatre located in Convent Garden, winning over 100 awards in its 27 year history.

Simon Dingemans’ Education

Masters in Geography